Development and validation of a prognostic scoring system for patients with colorectal cancer hepato-pulmonary metastasis: a retrospective study

• Published in: BMC cancer 2022-06, Vol.22 (1), p.643-13, Article 643
• Main Authors: Deng, Shenghe, Jiang, Zhenxing, Cao, Yinghao, Gu, Junnan, Mao, Fuwei, Xue, Yifan, Qin, Le, Liu, Ke, Wang, Jiliang, Wu, Ke, Cai, Kailin
• Format: Article
• Language: English
• Subjects: Calibration; Cancer specific survival; Care and treatment; Chemotherapy; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms; Complications and side effects; Evaluation; Health aspects; Hepato-pulmonary metastasis; Humans; Liver; Liver cancer; Lung cancer; Lung Neoplasms - therapy; Lymph nodes; Lymphatic system; Medical prognosis; Metastases; Metastasis; Neoplasm Staging; Nomogram; Nomograms; Nomography (Mathematics); Overall survival; Patient outcomes; Patients; Prognosis; Radiation therapy; Rare diseases; Regression analysis; Retrospective Studies; SEER Program; Statistical analysis; Tumors; Variables
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-022-09738-3

Hepato-pulmonary metastasis of colorectal cancer (CRC) is a rare disease with poor prognosis. This study aims to establish a highly efficient nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with colorectal cancer hepato-pulmonary metastasis (CRCHPM). We retrospectively analyzed the data of patients with CRCHPM from SEER database and Wuhan Union Hospital Cancer Center (WUHCC). A total of 1250 CRCHPM patients were randomly assigned to the training, internal validation, and external validation cohorts from 2010 to 2016.Univariate and multivariate cox analysis were performed to identify independent clinicopathological predictors of OS and CSS, and a nomogram was constructed to predict OS and CSS in CRCHPM patients. A nomogram of OS was constructed based on seven independent predictors of age, degree of differentiation, T stage, chemotherapy, number of lsampled lymph nodes, number of positive lymph nodes, and tumor size. Nomogram showed favorable sensitivity in predicting OS at 1, 3 and 5 years, with area under the receiver operating characteristic curve (AUROC) values of 0.802, 0.759 and 0.752 in the training cohort;0.814, 0.769 and 0.716 in the internal validation cohort;0.778, 0.756 and 0.753 in the external validation cohort, respectively. A nomogram of CSS was constructed based on three independent predictors of T stage, chemotherapy, and tumor size. The AUROC values of 1, 3 and 5 years were 0.709,0.588,0.686 in the training cohort; 0.751, 0.648,0.666 in the internal validation cohort;0.781,0.588,0.645 in the external validation cohort, respectively. Calibration curves, Concordance index (C-index), and decision curve analysis (DCA) results revealed that using our model to predict OS and CSS is more efficient than other single clinicopathological characteristics. A nomogram of OS and CSS based on clinicopathological characteristics can be conveniently used to predict the prognosis of CRCHPM patients.